text:
English 233: Introduction to Western Humanities -- Baroque & Enlightenment
An outline of Molière's Tartuffe -- Act Three
If you want to print this document from a KSU public computing lab, then to insure that colored type prints you will first need to go into the File menu, choose Page Set-up, and click on Black Type.
Act Three
i. Dorine forestalls Damis, the hot-headed son of Orgon, from rashly confronting Tartuffe with violent threats.
She reveals Elmire has sent for Tartuffe to sound him out.
Unable to persuade Damis to leave, and hearing the approach of Tartuffe, she shoves Damis in a closet.
ii. Tartuffe finally enters the action in his own person.
Catching sight of Dorine, he goes into a great show of piety
He calls offstage to his manservant Laurent, ordering him to hang up his hairshirt and his scourge.
He reproves Dorine for immodesty of dress.
He reproves her for the immodesty of her reply.
Dorine tells him Elmire wants to speak with him.
His reaction confirms Dorine's suspicions, confided to Damis in the previous scene, that Tartuffe is soft on his patron's wife.
iii. Tartuffe exposes his true nature to Elmire.
He humbly insists his numerous prayers for her recovery were too unworthy in God's eyes to have been responsible for it.
Elmire wants to discuss "a private matter" and expresses the hope that "you'll be entirely unconstrained and frank."
Mistaking her opening as a come-on, Tartuffe makes physical advances (pressing her fingertips, putting his hand on her knee, fondling the lace collar of her gown).
Elmire, trying to get back to her agenda, asks if he's heard of Orgon's intention to break his promise with Valère and give Mariane to Tartuffe.
Tartuffe assures her that he looks elsewhere for the bliss he desires.
Elmire, hoping to get him to resign Mariane in favor of celibacy, seeks agreement with her conclusion that "you care for nothing here below."
Tartuffe responds with a marvelous opportunistic caricature of orthodox theology and a declaration of his passion for Elmire.
Elmire rebukes him for not restraining his passion and thinking, before speaking, of the unsuitability of such a declaration to his character of piety.
Tartuffe: "I may be pious, but I'm human, too." And later: "I'm no angel, nor was meant to be."
[A declaration, notice, that the sequel will ironically call into question. ]
There follows a masterpiece of guile a calculatedly "passionate" (but nevertheless lustfully impassioned) pitch, which begins as an appeal to perversions of familiar religious concepts (the weakness of the flesh, the power of the celestial to inspire by its beauty, the conquering power of "seraphic glance," the nature of angelic goodness as the disposition to comfort distress, the nourishing function of divine grace ["sweet manna"], the grateful praise ["hosanna"] due to such kind condescension) and culminates in an appeal to down-to-earth considerations of worldly practicality (Tartuffe's concern for his own good name gives Elmire the assurance that hers will not be imperiled by bragging indescretion on his part).
Taking up the topic of tattling, Elmire seizes the opportunity to begin to close the door on the box she hopes she has got Tartuffe in: she asks him if he isn't afraid that she might tell her husband.
Tartuffe says he relies on her charity towards human weakness and ends with an appeal to her vanity: "I am not blind."
[Another declaration the sequel will play on in ironic ways. ]
Elmire promises discreetness on condition that Tartuffe promise
that he will use his influence with Orgon to get him to go forward with the marriage between Valère and Mariane, and
that he will renounce any "desire to dispossess / Another of his rightful happiness."
iv. Damis intervenes, rushing in from the closet where he has been hiding.
[Note the irony: what seems opportune to him is in fact most inopportune. He has apparently been deaf to what Elmire has been up to, presumably because he can hear only what is echoing in his own mind. As a result his attempt to seize victory turns out to seize defeat from the jaws of victory. Yet we might want to look behind this rashness to speculate on what motivates it. One plausible possibility: the son wants to shine in his father's eyes, by demonstrating his devotion to his father's and the family's interests. The urgency to do this might be referable to two factors at work in this situation: his wish, as a dependent, to demonstrate his suitability to carry out his father's tasks in the future, and his wish to displace a factor that has displaced him in his father's attention and affection. If Orgon were a mature individual, he would regard both as gratifying the first as reassuring, and the second as endearing. Since he is not, they are likely to strike him as threatening the first as reminding him of his mortality, and implying his displacement, the second as challenging his authority to choose his own objects of affection (regardless of obligations external to his whim). What is charming in a child, however, filial jealousy and the urge to prove oneself before others can be alarming in one who is supposed to be an adult: it is not fitting for Orgon to be driven, out of spite, to "show the others" (his dependents) his power to put them in their place. ]
He insists on exposing Tartuffe before his father.
Elmire remonstrates:
1) She has Tartuffe where she wants him.
2) She's promised silence.
3) "To make a scandal would be too absurd. / Good wives laugh off such trifles, and forget them; / Why should they tell their husbands, and upset them?"
Damis will have none of this, and insists on exploiting this heaven-sent opportunity of indubitable proof.
He runs down his grievances.
1) He has "swallowed my just wrath for too long."
2) He has too long "watched this insolent bigot bringing strife / And bitterness into our family life."
3) "Too long he's meddled in my father's affairs, / Thwarting my marriage-hopes, and poor Valère's."
4) "It's high time that my father was undeceived."
He insists that the suitable occasion has now arrived.
1) "And now I've proof that can't be disbelieved."
2) This "proof was furnished me by Heaven above."
3) Such an opportunity may not arise again: "It's too good not to take advantage of. / This is my chance, and I deserve to lose it / If, for one moment, I hesitate to use it."
Elmire tries to get a word in edgewise: "Damis . . ."
Damis cuts her off, insisting on having his satisfaction.
[Note that this is the same pattern we have noticed in the opening scene (Madame Pernelle's leave-taking) and that we will see once again (when Orgon refuses to listen to Damis' case against Tartuffe [III.vi.]) This "determined deafness" is a variation on the theme of "insistent blindness." ]
Although he insists that "I must do what I think right" (an unimpeachable principle of reason), it is clear that his judgment of what is right for the occasion is distorted by passion: "Madam, my heart is bursting with delight, / And say whatever you will, I'll not consent / To lose the sweet revenge on which I'm bent." In this heedless frame of mind he rushes forward: "I'll settle matters without more ado."
[The essential point to note is that Molière here is setting Damis up to be recognized later on in the scene which climaxes in his disinheritance by his father as "his father's son." If we do not recall this scene later on, we will not appreciate the comic irony in what Orgon does. ]
v. Orgon enters.
Damis informs him of what he has just witnessed.
Elmire expresses her misgivings (and exits).
vi. "Trial scene": the judge shows he has lost his judgment.
[This scene is one of those masterpieces of dramatic construction that repays careful detailed analysis. In this outline, though, we will confine ourselves to a sketch of a few main points.]
Tartuffe begins by confessing that he's "a wretched sinner, all depraved and twisted, / The greatest villain that has ever existed. My life's one heap of crimes, which grows each minute," and begs to be expelled from the house as punishment.
[Comic dramatic irony here: everything he says about the facts is true, but Orgon rejects these characterizations; everything he recommends is appropriate, but totally insincere.
It is remarkable that Orgon does not pardon these offenses, but does not take Tartuffe's confession seriously. (Neither of course does Tartuffe, but in a different way altogether!) Indeed, he declares Damis' charge to be a "foul. . . lie." What are we to make of this? What strange thought process what perversion of "reasoning" are we to imagine is going on in this man's mind? What premises might he have been stuffed with that he might be acting from here? A plausible possibility is that, for Orgon, such self-professions of personal depravity are to be understood as a kind of generic acknowledgment that every properly informed Christian should make. The source of this, we might suspect, is the standard insistence, in puritan sects (whether Calvinist Protestantism or Jansenist Catholicism), on admission of a certain "extreme" doctrine of Original Sin. Now since this applies to everybody, distinctions among sinners are effectively obliterated: everyone is equally (i.e., abominably) bad, and no one can escape this curse of Adam. And this has the effect of making such confessions a kind of pro forma ritual. (Note, by the way, that in the course of his self-accusation, Tartuffe never mentions the specific act of trying to seduce his patron's wife; he confines his auto-prosecution to completely general evil precisely the sort of stuff everyone is, in theory, guilty of.)
Ah, but there is a difference after all: there are those who, not having a proper conviction of sin, damnably proceed on assumption that their spiritual condition is reasonably healthy, and so are not moved to confess what they do not believe, and there are those who, convinced of their moral wretchedness, privately and publicly, and ask for divine forgiveness, for themselves and others. This is what a good Christian does. Moreover, by faith a Christian affirms that this forgiveness, if sincerely sought, will be forthcoming, and is atoned for in Christ's crucifixion. Such a person is, then, purified.
Now Tartuffe does these things. Therefore he is a good Christian and pure. Therefore (here's the absurd non-sequitur) he wouldn't have done the ugly thing that Damis says he did. Therefore Damis is lying. The key is: form has become an effective substitute for content. When the evidentiary process is reduced to such a caricature of reasoning, it backfires: the criminal is acquitted as innocent, and his accuser convicted of a "deceitful" attempt to "stain his purity." A deep comic irony here is that, on some level, Orgon has conceived the judgment (shared by Molière!) that these elaborate general declarations of grave depravity are "theatrical," and not to be taken seriously as confessions of specific sins. Orgon in effect takes this self-condemnation as a protestation that "I am not the sort of man who would do what I'm charged with doing." ]
Orgon breaks in to upbraid Damis for telling shameful lies and, when Damis protests, tells him to shut up.
[This stifling of his son's attempts to speak is made comically flagrant by arranging for it to occur a total of five times (ll. 18, 37, 38, 39, 45) in the course of this short scene (three of these instances occurring in such rapid succession that the entire series of exchanges takes place within three lines! (See the note on Damis' conduct in the previous scene.) ]
Tartuffe advises Orgon to listen to and believe Damis.
[Here we get (from this consummate con-artist) a mini-sermon on faith, and the problems of trusting appearances.]
He begs Damis to revile him with the most shameful names, because "I've earned them all, and more."
Orgon launches into a comic routine of switching rapidly back and forth between pleading with Tartuffe and upbraiding Damis.
[Note the themes here: the son is a "monster" and "villain": "heartless," an "ingrate"; Tartuffe is continually addressed as "Brother" and seen as the soul of offended virtue.]
Tartuffe begs Orgon to pardon Damis.
[Note the brilliant shift of ground here! Damis is, of course, innocent of the charges Orgon is lodging. Yet, inasmuch as pardon is appropriate only when one has committed an offense, Tartuffe's intercession encourages Orgon's delusion that Damis is in the wrong. Additionally, of course, Tartuffe's plea amounts to a projection of his own condition upon Damis, since it is he (Tartuffe) who is in need of pardon.]
Orgon is overwhelmed by this demonstration of incredible virtue: "Such goodness cannot be!"
Damis correctly sarcastically admires this "true charity."
Hushing Damis once more, Orgon launches into a tirade against his family for their bad motives (ill-will towards Tartuffe), and their manipulative trickery in trying to alienate him from this saintly man.
[Note that Orgon has so identified with Tartuffe, whom he begins by characterizing as a victim of the family's maliciousness, that he shifts into seeing himself as the victim of this same depraved collective will.]
He resolves to "spite this household and confound its pride," and to do so by giving his daughter to Tartuffe.
Damis asks incredulously whether he is going "to force her to accept [Tartuffe's] hand."
[Damis has raised a distinct issue: what if Mariane doesn't want to marry Tartuffe?]
Orgon declares yes, he'll "defy you all."
[In other words, that Mariane doesn't want to marry Tartuffe is, in his present mood, a mark in favor of his resolution, whose point is to spite his family.]
He orders Damis to ask Tartuffe's pardon.
Damis refuses.
Enraged at Damis' insulting Tartuffe and defying his father,
expels him from the house
resolves to disinherit him, and
curses him.
viii. Damis having left, Tartuffe moves into a new phase of his act.
He begins to harp upon his suffering at
being blackened in Orgon's eyes
the quarrels his presence occasions in the household.
He proposes to leave.
[Note the similarity of Tartuffe's behavior to coyness in courtship. ]
Orgon will have none of it.
Tartuffe proposes keeping away from Orgon's wife.
Orgon refuses again, out of spite: "whatever they may say / It pleases me to vex them, and for spite, / I'd have them see you with her day and night."
Then he lets his spite carry him to the climactic follies:
"What's more, I going to drive them to despair / By making you my only son and heir" and (!)
"This very day, I'll give to you alone / Clear deed and title to everything I own."
[What's the connection with Damis' behavior in Scene iv?]
He declares that "[a] dear, good friend and son-in-law-to-be / Is more than wife, or child, or kin to me."
[Can you put your finger on what is absurd about this?]
He asks Tartuffe ("dearest son") whether he will accept his offer.
And Tartuffe's blasphemous reply: "In all things, let the will of Heaven be done."
Orgon's final couplet embraces two strong motifs:
"Poor fellow! Come, we'll go draw up the deed.
Then let them burst with disappointed greed!"
Copyright (c) 1996 by Lyman Allen Baker.
Permission granted for non-commercial educational use; all other rights reserved.
Revised 23 November 1996.


text:
3 2 2
Located in the heart of Werribee with an abundance of local amenities within arms reach, whether youre looking for your first or next investment, this is the property for you!
Boasting three great sized bedrooms (master with BIR and en suite) as well as a renovated main bathroom. This is accompanied by two separate living zones including a formal lounge and dining/open study and a spacious kitchen meals area.
The kitchen boasts a gas cook top, gas oven, range hood, stainless steel dishwasher and plenty of bench and storage space.
The home is situated on approximately 533m2 of land with a great sized outdoor pergola and plenty of room for the kids and pets to play.
It is currently leased until March 2019 for $1390.00 per calendar month.
Other features include ducted heating, floorboards, window furnishings, light fittings, spacious laundry, flyscreens, security doors and an oversized double car garage.
SMS 282GREAVES to 0428 440 958 for full property details.
Get in touch with our team at First National Real Estate Westwood
Authorised Principal, Administration, Commercial Sales, Property Management, Rural, Sales

subset: commoncrawl


text:
A Slippery Slope
Despite a two-year high in earnings growth, the outlook for future quarters may be too bullish
Corporate profits, which seemed to be on the mend in 2002's first half, have hit an air pocket. In recent weeks, companies such as Oracle, Electronic Data Systems, JDS Uniphase and J.P. Morgan Chase have issued ominous warnings about profits in the third quarter and beyond. That has triggered a pick-up in earnings-estimate reductions by Wall Street analysts, adding to the pressure on stocks.
According to Thomson First Call, expectations for third-quarter earnings growth for the companies in the Standard & Poor's 500 stock...


text:
Zenon Wozniak
Director Projects
First Quantum Minerals Ltd
Qualified Engineer with 30 years of varied and challenging experience in multiple countries. Initially involved in the Oil and Gas sector, including engineering, design and construction. Subsequently moved into the Mining sector including detailed design and commissioning, Project Engineering and Project Management. Has worked on numerous lump sum 'hard money' contracts, and mining projects for various commodities including copper, nickel, gold, diamonds. Relocated to Chile in 1994 to 1998 to undertake a number of mining projects, and has direct project execution experience in Latin America, Africa, Australasia and Europe. Joined First Quantum Minerals in 2003 to manage FQM's projects, commencing with the original Kansanshi development onwards. Implemented continual improvement of FQM's project execution strategy, and currently Director Projects with a project development portfolio in excess of $10B.


text:
Pajucara Flat features a sauna and a fitness room, as well as air-conditioned accommodation with free WiFi in Maceió, an 18-minute walk from Jatiuca Beach.
All units include a fully equipped kitchen, allowing guests to prepare their own meals. A microwave and coffee machine are also provided.
The apartment offers an outdoor pool.
A terrace is available for guests at Pajucara Flat to use.
Ponta Verde Beach is 1.6 km from the accommodation. Maceio/Zumbi dos Palmares International Airport is 19... km from the property.
|Rua Julio Plech Filho 60


text:
Woodson, J. (2014). Brown girl dreaming. New York: Penguin.
Jacqueline is a young girl who uses poetic verse to tell of her travels from South Caroline to New York during the 1930s and 1970s. Her experiences with segregation and racism are evident throughout her story. There is also a mix of personal and familial issues expressed in her words during the Civil Rights Movement.
Textbook Assignment:
Jacqueline Woodson uses poetry to tell about her own personal experiences as a child during the Civil Rights movement.
How to Sell the Book-
This book is perfect for a student who wants to learn about the history of the Civil Rights Movement from the perspective of a child. It is also great for students who feel disenfranchised and need inspiration.
Three Books by the Same Author-
- Between Madison And Palmetto (1993)
- Different- fiction novel about two friends
- Feathers (1992)
- Similar- same time period (1970s)
- Different- novel format; not autobiographical
- Locomotion (1990)
- Similar- written in poetic verse
- Different- not autobiographical


text:
Home Interior Designer. Can inspire you and make suggestions in updating your home or living area when it is outdated. There are lots of ideas which can help you transform the complete look of your house. For those who have the best ideas, you may create a distinctive space having an outstanding style. These days, most of the people feel that 'simple is better'. If you notice that many houses built today have minimalist style. If you are home renovation, you want fresh ideas. There are numerous home ideas that can be used to beautify your own home.
home interior designer, home interior designers in bangalore, home interior designer near me, home interior designer in pune, home interior designer salary, home interior designers melbourne, home interior designers in noida, home interior designer in delhi, home interior designers in coimbatore, home interior designer jobs


text:
IND vs ENG, Vizag Test, Day One: Virat Kohli, Cheteshwar Pujara tons lift hosts
Virat Kohli and Cheteshwar Pujara notched up centuries as India ended day one on top against England in Vizag. Catch all highlights of the first day of the second Test between IND v ENG here.cricket Updated: Nov 17, 2016 17:05 IST
Relive all the highlights of the first day of the second Test between IND vs ENG, Day 2 of Vizag Test here.
Virat Kohli notched up his fourth 150-plus score in Tests while Cheteshwar Pujara scored his 10th Test ton and fourth against England. Their 226-run stand has given India the advantage heading into day 2 as they finished on 317/4 at stumps. (UPDATES)
If you can't view the scorecard, click here


text:
The Macro Ring Lite MR-14EX II is ideal for EOS quality close-up photography when used in conjunction with one of Canon's EF macro lenses. Redesigned as a perfect complement to contemporary digital SLR setups, it is the most advanced macro flash Canon has ever produced. Sophisticated white LED focusing lamps and two forms of modeling lights make for easy and accurate previewing of lighting effects. Infinitely adjustable in any lighting condition with its illuminated dot-matrix LCD, the Macro Ring Lite MR-14EX II has 12 custom functions and supports E-TTL wireless autoflash when linked with one or more Speedlite 600EX-RT flashes. All this in a refined, compact design with shorter recycling times than its predecessor makes the Macro Ring Lite MR-14EX II a reliable, customizable choice.
From drivers and manuals to diagnostic tools and replacement parts, Dell Product Support has you covered!
Add the products you would like to compare, and quickly determine which is best for your needs.


text:
Original Research ARTICLE
The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis
- 1Univ. Lille, U995 – LIRIC – Lille Inflammation Research International Center, Lille, France
- 2INSERM, U995, Lille, France
- 3CHU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Claude Huriez, Lille, France
- 4CHU Lille, Service de Chirurgie Digestive et Transplantations, Hôpital Claude Huriez, Lille, France
The etiology of inflammatory bowel diseases remains largely unknown. We previously demonstrated that the expression of the peroxisome proliferator activated receptor-gamma (PPARγ) is downregulated in colonic epithelial cells of patients with ulcerative colitis (UC). PPARγ is a nuclear receptor that modulates inflammation. We hypothesized that its deficiency may play a role in the loss of intestinal homeostasis through the control of immunomodulatory factors. We found that thymic stromal lymphopoietin (TSLP), an epithelial cytokine with pleiotropic functions, is regulated by PPARγ. While this cytokine possesses two isoforms, only the short form (sfTSLP) was regulated by PPARγ. sfTSLP mRNA expression was decreased both in PPARγ knock-down Caco2 cells and cells treated with PPARγ antagonist, whereas PPARγ agonists induced the expression of sfTSLP in Caco2 and T-84 cells. The response element activated by PPARγ was identified in the promoter of the sfTSLP gene by chromatin immunoprecipitation and gene reporter assays. The expression of sfTSLP was significantly decreased in the colonic mucosa of UC patients compared to controls and was correlated with PPARγ expression. Our results identified sfTSLP as a new PPARγ-target gene and support the hypothesis that, in UC, PPARγ deficiency in colonic mucosa could play a role in the loss of intestinal tolerance through an impaired sfTSLP expression.
In humans, the intestinal mucosal surface is an essential exchange area between the host and its environment. In the context of intestinal homeostasis, mucosal immune cells must be able to tolerate commensal and food antigens while keeping their ability to fight pathogens (1). A fundamental actor in this dialog between luminal antigens and mucosal leukocytes is the intestinal epithelial cell (IEC) (2). Although initially considered as a simple physical barrier, it is now clear that IECs actively participate to the induction and maintenance of intestinal homeostasis. For instance, IECs respond to microorganism antigens or metabolites by increasing the synthesis of mucus, the secretion of anti-microbial peptides and/or by promoting immunoglobulin A transcytosis (2). In addition, IECs have the ability to secrete cytokines and chemokines at their basal pole, thereby regulating the functions of the underlying intestinal immune cells (2). Notably, it has been demonstrated that, through the secretion of immunoregulatory molecules such as transforming growth factor-β (TGF-β), thymic stromal lymphopoietin (TSLP), or retinoic acid, IECs have the capacity to regulate the ability of dendritic cells to induce regulatory T cells (3–5).
Recent studies suggest that IEC dysfunctions may actively participate in the pathogenesis of ulcerative colitis (UC) (6, 7). UC (along with Crohn's disease) is one of the major types of inflammatory bowel diseases (IBD) which are chronic, complex, relapsing immune-mediated diseases of the gastrointestinal tract of unknown etiology (7, 8). Our previous work has demonstrated that the expression of peroxisome proliferator activated receptor-gamma (PPARγ) is reduced in the colonic epithelial cells (CEC) of individuals with UC (9, 10). PPARγ is a nuclear receptor which plays a key role in lipid and glucose metabolisms as well as in gut homeostasis (11, 12). Conditional knock-out mice in which PPARγ expression is selectively ablated in CECs demonstrate an increased susceptibility to DSS-induced colitis (13). Conversely, PPARγ synthetic agonists inhibit inflammation and reduce disease severity both in experimental models of colitis and in UC patients (12, 14–16). These results clearly underline the importance of CEC in controlling the magnitude of the inflammatory response in the gut, at least in part, in a PPARγ-dependent manner. Despite these observations, as well as the abundance of PPARγ in the colon (17), how this nuclear receptor exerts its anti-inflammatory functions within the intestine is poorly known and most of its target genes, notably in CEC, remain to be characterized.
Our hypothesis is that PPARγ deficiency in CEC during UC might play a role in the loss of intestinal homeostasis trough the regulation of immunoregulatory factors. One possibility would be the potential role of PPARγ in the control of cytokine production by CEC. In addition, CEC express some cytokine receptors and, consequently, are able to respond to the cytokine environment within the intestinal mucosa (18, 19). The aim of this study was therefore to identify PPARγ target genes involved in CEC immune functions relevant to UC physiopathology. Our results identified the gene encoding the short isoform of TSLP (sfTSLP) as a new gene regulated by PPARγ in CEC and support the hypothesis that, in UC, the impaired expression of PPARγ in colonic mucosa could play a role in the loss of intestinal tolerance through a decrease of sfTSLP expression.
Materials and Methods
Cell Culture and Stimulation
Caco-2 cells (ATCC® CRL-2102™) were grown in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen, Life Technologies, Cergy-Pontoise, France) supplemented with 20% fetal calf serum (FCS, Dutscher, Brumath, France), 1% penicillin-streptomycin (Invitrogen, Life technologies), and 1% non-essential amino acids (Invitrogen, Life technologies). T84 cells (ATCC® CCL-248™) were grown in a 1:1 mixture of Ham's F12 medium and DMEM supplemented with 5% FCS and 1% penicillin-streptomycin. H292 cells (ATCC® CRL-1848™) were grown in RPMI-1640 supplemented with 10% FCS and 1% penicillin-streptomycin. Generation and maintenance of PPARγ knock-down Caco-2 cells were described in Ref. (10). All cell lines were cultured as confluent monolayers at 37°C in a controlled, 5% CO2 atmosphere.
For cell stimulations, 1 × 106 cells per well were seeded in 6-well plates. Serum deprivation was used 16 h prior to stimulation in order to synchronize the cells. Cells were treated with GED (30 mM; Nogra Pharma Ldt, Italy), pioglitazone (10 µM; Sigma-Aldrich), 5-ASA (30 mM; Sigma-Aldrich), GW9662 (10 µM, Sigma-Aldrich), or poly I:C (10 µg/L; Invivogen). When necessary, the DMSO vehicle (Sigma-Aldrich) was used as control. After 24 h of stimulation, cells were washed twice with sterile PBS and were lysed with 1 ml of TRIzol® reagent (Invitrogen™, Cergy Pontoise, France). The plates were frozen at −80°C for subsequent RNA and protein extraction. Cell stimulations were performed in 3 or 6 replicates.
Culture of polarized Caco-2 cells was done as follow: 3 × 104 cells were seeded on Transwell® filters in 12-well plates. During the first 7 days, complete culture medium (DMEM containing FCS) was added both to the upper and lower compartment. Cell polarization is obtained between days 8 and 21 of culture by culturing cells with DMEM containing FCS in the lower compartment and DMEM without FCS in the upper compartment. Measurement of the Trans-Epithelial Resistance (TER) was done every 2 days (before medium replacement) to check cell differentiation and integrity of the cellular barriers. At day 21, polarized Caco-2 cells were stimulated with PPARγ agonist. After 24 h of stimulation, cells were washed twice with sterile PBS and were lysed with 1 ml of TRIzol® reagent.
RNA Extraction
RNAs were isolated with the TRIzol® reagent according to the manufacturer's instructions and resuspended in RNAse-free, DEPC-water. The purity and concentration of the RNAs were evaluated by UV spectroscopy on a Nanodrop system (Nyxor Biotech, Paris, France).
Quantitative PCR (qPCR)
Expression of genes was quantified by qPCR of corresponding reverse transcribed mRNA. 1 µg of total RNA was reverse-transcribed into cDNA using the High Capacity cDNA Archive kit (Applied Biosystems). Amplification was performed using an ABI PRISM StepOnePlus detection system (Applied Biosystem) using Power SYBR® Green PCR master Mix (Applied Biosystem). Primer pairs were chosen with qPrimer depot software.1 See Table S1 in Supplementary Material for the oligonucleotides used in this study. Quantification of qPCR signals was performed using ΔCt relative quantification method using GAPDH as a reference gene. Values were represented in terms of relative quantity of mRNA level variation or fold increase compared to control conditions.
Protein Analysis
Peroxisome proliferator activated receptor-gamma protein was detected from total proteins obtained after TRIzol extractions. Proteins were separated by polyacrylamide gel electrophoresis and electroblotted on nitrocellulose membrane. PPARγ was detected using a monoclonal rabbit antibody (C26H12) as primary antibody (Cell Signaling Technology®) and goat anti-rabbit IgG peroxydase conjugate (Jackson ImmunoResearch). Nitrocellulose membranes were probed with a mouse monoclonal anti-β actin antibody (Sigma-Aldrich®, France) to assess equal protein loading.
Short form TSLP protein was detected by immunoprecipitation followed by western-blot analysis. 6 million of Caco-2 cells were used for each immunoprecipitation. When indicated, cells were stimulated during 24 h in 100 mm cell culture dishes. Cells were washed and scraped in PBS buffer, then lysed in IPH buffer (50 mM Tris pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% NP40, and protease inhibitors) for 1 h in ice. After centrifugation 15 min at 15,000 g, the supernatants were recovered and dosed. The same amount of protein was engaged in each immunoprecipitation (1.5 mg). 2 µg of TSLP antibody (Clone # 184638 rabbit polyclonal, Abcam) were added and the tubes were incubated overnight at 4°C under rotation. The next day, a mixture of protein A/G agarose beads (Santa Cruz) was added and incubation was continued 2 h at 4°C under rotation. Then, beads were washed 5 times with IPH buffer followed by denaturation in Laemli sample buffer at 95°C for 5 min. Immunoprecipitated material was analyzed by western-blot using the TSLP antibody (Clone # 184638 rabbit polyclonal, Abcam) as primary antibody and goat anti-rabbit IgG peroxydase conjugate (Jackson ImmunoResearch). β-actin protein was detected to assess equal protein engagement (1% input).
In Silico Analysis of sfTSLP Promoter
Presence of PPAR response element sequences were investigated in silico in the promoter of the sfTSLP. 1000 base pairs upstream of the transcription initiation site were analyzed by two different softwares: NUBIScan2 (20) and PPRE Search3 (21).
Chromatin Immunoprecipitation Experiments
The physical binding of PPARγ onto the sfTSLP gene promoter was studied by ChIP experiments in Caco-2 cells (10 × 106 cells) stimulated for 24 h with 30 mM GED in 150 mm cell culture petri dishes. Caco-2 cells were synchronized by the addition of serum-free medium for 16 h and then stimulated for 24 h using the protocol described previously. Cells were then rinsed with PBS and the protein–DNA complex was fixed by adding 10% PFA for 30 min at room temperature. This binding was stopped by the addition of glycine (0.125 M). Cells were collected by scrapping in cold PBS and protease inhibitors (Sigma). The cell pellet obtained by centrifugation was taken up in 300 µl SDS buffer (1% SDS, 10 mM EDTA, 50 mM Tris–HCl pH 8, protease inhibitors + PMSF 0.1 mM) and sonicated (Diagenode, BioruptorUCD200TM-EX) for 30 s, followed by 30 s' resting time. For each immunoprecipitation, 125 µL of crosslinked sonicated sample was diluted with 225 µL of IP buffer (1% triton X-100, 150 mM NaCl, 2 mM EDTA, 20 mM Tris–HCl pH 8.1, and protease inhibitors) and precleared for 4 h by adding 40 µL of protein A/G beads (50% slurry protein A/G Sepharose, Clinisciences) and 5 µg of salmon sperm DNA (Invitrogen). Complexes were immunoprecipitated with specific anti-PPARγ antibodies (C26H12 rabbit monoclonal antibody, Cell Signaling) by incubation overnight at 4°C under rotation. Immune complexes were recovered by adding 40 µL of protein A/G Sepharose (50%) plus 2 µg salmon sperm DNA and incubated for 4 h at 4°C. The beads were washed twice in wah buffer 1 (0.1% SDS, 1% Triton X-100, 150 mM NaCl, 0.1% Deoxycholate, 1 mM EGTA, 2 mM EDTA, 20 mM Tris–HCl pH 8.0), twice in wash buffer 2 (0.1% SDS, 1% Triton X-100, 500 mM NaCl, 0.1% Deoxycholate, 1 mM EGTA, 2 mM EDTA, 20 mM Tris–HCl pH 8.0), once in wash buffer 3 (0.25 mM LiCl, 0.5% Deoxycholate, 0.5% NP40, 0.5 mM EGTA, 1 mM EDTA, 10 mM Tris HCl pH 8.0), and 3 times in wash buffer 4 (1 mM EDTA, 10 mM Tris–HCl pH 8.0). The co-immunoprecipitated DNA was then extracted with 150 µL of extraction buffer (0.1 M NaHCO3, 1% SDS). Cross-linking was reverse overnight at 65°C. DNA was then purified using the PCR Clean-up kit (Macherey-Nagel) and analyzed by PCR.
Genomic DNA fragments were cloned upstream of the luciferase reporter gene (plasmid pGL4.10 [Luc2]; Promega). The fragment corresponding to the 1,000 bp upstream of the transcription initiation site of the human sftslp gene (construction "Prom TSLP2") was obtained by PCR from genomic DNA of Caco-2 cells (sense oligonucleotide 5′-CGCTCGAGGGATGTCTATCCTTTGCTAAAG-3′; antisense oligonucleotide 5′-CGAAGCTTGGCGGAGGGCACTCGTCGCGAAAAG-3′). The fragment corresponding to the 548 base pairs upstream of the transcription initiation site of the human sftslp gene (construct "Prom TSLP2Δ1") was obtained by PCR from genomic DNA of Caco-2 cells (sense oligonucleotide 5′-CGCTCGAGGGTACCTGAGTGGAAACTGTT-3′; antisense oligonucleotide 5′-CGAAGCTTGGCGGAGGGCACTCGTCGCGAAAAG-3′). The PCR products were cloned into a TOPO pCR4 vector (TOPO TA cloning, Invitrogen) and then sequenced in order to check for potential Taq Polymerase errors. For each construct, a mutation-free fragment was subcloned into the vector pGL4.10 [Luc2] (Promega) using the XhoI/HindIII restriction sites introduced into the oligonucleotides (underlined in the sequence).
Transient Transfections and Reporter Gene Assays
Reporter plasmids and the empty vector control were transiently transfected in Caco-2 cells using Nucleofector™ Technology. For each condition, 2 × 106 cells (50–70% confluency) were transfected with 2 µg of plasmids using SE 4D-Nucleofector solution and program DS-123. Transfected cells were seeded in 48-well plates at 100,000 cells per well and treated by PPARγ agonists for 24 h. Luciferase activity was measured using the luciferase assay kit (Promega) in fluorometer (FLUOstar Omega, BMG Labtech) according to the manufacturers' instructions. Total protein contents were dosed using Bradford reagent (Euromedex) and used to normalize luciferase activity.
Patients and Tissue
A local ethics committee (Comité de Protection des Personnes Nord Ouest IV, CHRU Lille, France) approved the study and all subjects gave informed consent (No. DC-2008-642). Surgical colonic samples were obtained from patients with an established diagnosis of UC according to international criteria and from control patients (patients underwent surgery for colorectal cancer and patients for diverticulitis of the sigmoid). The detailed characteristics of patient cohort are given in Table S2 in Supplementary Material. Colonic epithelial cells were isolated from resected colonic specimens as previously described (10).
The data are presented as mean with SEM or SD. All graphs were plotted and analyzed with GraphPad Prism 5 Software (San Diego, CA, USA) using a two-tailed non-parametric Mann–Whitney test. P values < 0.05 were considered statistically significant.
Reduced Expression of the Gene Encoding TSLP in PPARγ Knock-Down Cells
In order to identify factors whose expression depends on PPARγ in the CEC and which might be involved in the immunoregulatory properties of these cells, we have used a targeted approach and first investigated the mRNA expression of some genes encoding cytokines and cytokine receptors in PPARγ knock-down colonic epithelial Caco-2 cells. To this end, we used a Caco-2 ShPPARγ cell line that stably expresses a short hairpin anti-sense RNA against PPARγ, leading to specific downregulation of PPARγ (10) (Figure 1A). Compared to control cells (Caco-2 ShLuc cells, expressing a control shRNA directed against the luciferase gene), the expression of PPARγ in Caco-2 ShPPARγ cell line was reduced approximately by 70% and this decrease was equivalent to those we observed in CEC from UC patients (9, 10).
Figure 1. TSLP expression is strongly reduced in peroxisome proliferator activated receptor-gamma (PPARγ) knock-down Caco-2 cells. (A) Caco-2 colorectal cell line knock-down for PPARγ (ShPPARγ) expressed significantly fewer PPARγ transcripts and protein compared to ShLuc control cells. Quantitative expression of mRNA was assessed by quantitative PCR (qPCR). Results represent the mean values of sextuplicate ± SD of the fold change of PPARγ expression normalized to GAPDH level. The expression level measured in ShLuc cells (arbitrarily defined as one) was used as reference. Protein level was assessed by Western blot. The results represent a triplicate of the same clone of ShLuc and ShPPARγ Caco-2 cells, respectively. (B) Targeted approach in order to identify genes with different expression profile in PPARγ knock-down Caco-2 cells (ShPPARγ) compared to control cells (ShLuc)—Results of qPCR analysis. We selected various genes potentially expressed by intestinal epithelial cells and tested their expression in ShPPARγ/ShLuc Caco-2 cells. Results represent the mean ± SEM (2 independent experiments in triplicate) of the fold change of selected genes expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. (C) qPCR analysis of TSLP gene expression in PPARγ knock-down Caco-2 cells (ShPPARγ) compared to control cells (ShLuc). Results represent mean ± SEM (5 independent experiments in triplicate or sextuplicate, n = 18) of the fold change of TSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. Caco-2 cells were stimulated for 24 h with GW9662. Results represent mean ± SEM (2 independent experiments in triplicate or sextuplicate, n = 9) of the fold change of TSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. **P < 0.01; ***P < 0.001; ns, not significant. MCP-1, Monocyte chemoattractant protein-1; LTβ, Lymphotoxin-β; IL-1β, Interleukin-1 β; TSLP, thymic stromal lymphopoietin; TNF, tumor necrosis factor; CCL28, Chemokine (C-C motif) ligand 28; BAFF, B-cell activating factor; IL-10Rα, interleukin-10 receptor α chain; CCL20, Chemokine (C-C motif) ligand 20; TGFβ, Transforming growth factor β; RALDH-1, retinaldehyde dehydrogenase 1; IL-13Rα1, interleukin-13 receptor α1 chain; IL-22R, interleukin-22 receptor; IL-10Rβ, interleukin-10 receptor β chain.
Thus, using this system, we observed that the expression of some pro-inflammatory genes such as interleukin-1β or MCP-1 was significantly upregulated in Caco-2 ShPPARγ cells (Figure 1B). More remarkably, we observed a dramatic decrease of expression of the mRNA encoding TSLP cytokine (Figure 1B). To confirm this result, we measured the expression level of TSLP mRNA in independent experiments and systematically found that TSLP mRNA level was significantly reduced by about 90% in ShPPARγ Caco-2 cells compared to the ShLuc cells (Figure 1C). In order to exclude the possibility of off-target effects of anti-sense RNA, we investigated the effect of the PPARγ antagonist GW9662. We observed that GW9662 also significantly suppressed TSLP expression in Caco-2 cells (Figure 1C). These first results demonstrate that TSLP expression is abrogated in Caco-2 cells when PPARγ is inhibited.
Activation of PPARγ-Induced TSLP Expression
To further explore the regulation of TSLP expression by PPARγ in CECs, we measured TSLP mRNA expression after stimulation of Caco-2 cells with 3 different PPARγ agonists: pioglitazone (Pio; 10 µM), a well characterized PPARγ ligand belonging to the anti-diabetic thiazolidinedione drug class (22), 5-amino salicylic acid (5-ASA; 30 mM) (23), and a new PPARγ modulator, we developed and named GED-0507-34-Levo (GED; 30 mM) (24). All PPARγ ligands tested were able to significantly induce the expression of TSLP mRNA in Caco-2 cells (Figure 2A). These results were confirmed in another IEC line (T84), which expresses both TSLP and PPARγ (Figure 2B). In order to confirm the involvement of PPARγ in this process, we next assessed the induction of TSLP mRNA expression by PPARγ ligands in PPARγ knock-down Caco-2 cells. We first observed that 5-ASA and GED significantly induce TSLP mRNA expression in Caco-2 ShLuc control cells in an identical manner than in normal Caco-2 cells (Figure 2C), while in ShPPARγ Caco-2 cells, both 5-ASA and GED-dependent expression of TSLP mRNA were strongly reduced (Figure 2C). This result shows that PPARγ potentiates tslp expression in Caco-2 cells. Taken together, our results support the hypothesis that PPARγ is a key factor controlling TSLP expression in CEC.
Figure 2. Activation of peroxisome proliferator activated receptor-gamma (PPARγ) in IEC cell lines induced TSLP expression. (A) qPCR analysis of TSLP gene expression in stimulated Caco-2 cells. Cells were stimulated for 24 h with each agonist. Results represent mean ± SEM (2 independent experiments in triplicate or sextuplicate, 9 < n < 12) of the fold change of TSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. (B) qPCR analysis of TSLP gene expression in stimulated T84 cells. Cells were stimulated for 24 h with each agonist. Results represent mean ± SEM (2 independent experiments in triplicate or sextuplicate, 9 < n < 12) of the fold change of TSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. (C) qPCR analysis of TSLP gene expression in ShPPARγ cells compared to ShLuc cells stimulated by GED and 5-ASA. Results represent mean ± SEM (two independent experiments in triplicate, n = 6) of the fold change of TSLP gene expression normalized to GAPDH level. The expression level measured in control cells (unstimulated ShLuc cells) was used as reference and defined as 1. **P < 0.01; ***P < 0.001.
PPARγ Regulates the Expression of the sfTSLP
Three distinct mRNA variants can be transcribed from the human tslp gene, but only two encode functional protein. Variant 1 is composed of 4 exons which encode the long form TSLP (lfTSLP) of 159 amino acids length. Variant 2 is composed of 2 exons which encode the sfTSLP consisting in the 63 and/or 60 C terminal amino acids of long TSLP (Figure 3A). It is only very recently that studies have been interested in distinguishing these 2 isoforms and their possible distinct functions (25–27). It appears that lfTSLP mRNA and protein are upregulated in response to inflammatory stimuli and therefore associated to inflammatory conditions such as asthma, dermatitis, or IBD (26). Conversely, sfTSLP is constitutively expressed in healthy mucosa of the digestive tract as well as in the skin (25, 26). The cues that drive this distinct expression pattern are unknown. To test the implication of PPARγ, we designed isoform-specific primers (Figure 3A; Table S1 in Supplementary Material for primer sequences) and assessed the transcription of the two TSLP variants. lfTSLP transcript was amplified from bronchial epithelial cells (H292) stimulated with polyinosinic-polycytidylic acid (polyI:C) (Figure S1 in Supplementary Material), but no lfTSLP transcript was detected in our quantitative RT-PCR experiments in Caco-2 and T84 cells, both at the basal level nor after stimulation with PPARγ agonists. On the other hand, the three PPARγ agonists were all able to significantly induce sfTSLP mRNA expression, both in Caco-2 and T84 cells (Figures 3B,C). The Caco-2 cells have the ability to spontaneously differentiate (when reaching confluence) into polarized IECs which express, for instance, tight junction proteins and develop transepithelial electric resistance. In order to test whether the induction of sfTSLP by PPARγ agonist was maintained or modified by Caco-2 cells differentiation, we also assessed the induction of sfTSLP by GED in polarized Caco-2 cells. To this end, Caco-2 cells were grown on transwell filters during 21 days to allow cell polarization, and then cells were stimulated with PPARγ agonist for 24 h. In these conditions, activation of PPARγ with GED still resulted in a significant three-fold induction of sfTSLP mRNA expression (Figure 3B). We next investigated the stimulation of sfTSLP mRNA expression by PPARγ ligands in PPARγ knock-down Caco-2 cells. We found that 5-ASA and GED significantly induce sfTSLP mRNA expression in Caco-2 ShLuc control cells (to the same extend to what we observed in Figure 2C with non-isoform specific primers), while in ShPPARγ Caco-2 cells, both 5-ASA and GED-dependent expression of sfTSLP mRNA were strongly compromised (Figure 3D). Treatment of Caco-2 cells with the PPARγ antagonist GW9662, confirmed that blocking PPARγ activity significantly impact the expression of sfTSLP (Figure 3D). Finally, we tried to confirm these results by detecting and evaluating sfTSLP protein level in stimulated Caco-2 cells. Given that the amino acid sequence of sfTSLP perfectly overlap the C-terminal sequence of lfTSLP, it is not possible to have an antibody specifically directed against sfTSLP. However, by using an antibody raised against the C-terminal part common to both proteins, it should be possible to distinguish the two isoforms in western-blot analysis due to their different molecular weights [apparent molecular weight of 23 kDa for lfTSLP and 9 kDa for sfTSLP (25)]. Nevertheless, we never succeeded to detect sfTSLP in protein extracts from Caco-2 cells (stimulated or not) directly in western-blot analysis (not shown). We hypothesized that it could be due to a low level of sfTSLP protein expression and, thus, in order to increase TSLP protein concentration, we first performed an immunoprecipitation step before western-blot analysis. This approach allowed us to detect sfTSLP protein in Caco-2 stimulated with GED as well as in Caco-2 ShLuc/ShPPARγ (Figure 3E). No signal was observed in the lanes corresponding to the immunoprecipitation control (Figure 3E "IP beads," which correspond to the immunoprecipitation of protein extracts without any anti-TSLP antibody), whereas, we detected a band migrating just below 10 kDa in the lane corresponding to the proteins immunoprecipitated with anti-TSLP antibody (Figure 3E, "IP TSLP"). We concluded that this band corresponds to sfTSLP protein. Moreover, we observed a stronger signal in the lane corresponding to proteins immunoprecipitated from Caco-2 cells stimulated with GED (Figure 3E, GED lane "IP TSLP") compared to unstimulated Caco-2 cells (Figure 3E, control lane "IP TSLP") and fewer sfTSLP were immunoprecipitated from ShPPARγ Caco-2 cells than from ShLuc Caco-2 cells (Figure 3E, ShPPARγ "IP TSLP" lanes compared to ShLuc "IP TSLP" lanes). Given that equal amount of protein was engaged in each immunoprecipitation, we concluded from this experiment that modulation of PPARγ in Caco-2 cells impacts sfTSLP protein expression. Taken together, the results of this part strongly suggest that PPARγ is an important transcription factor controlling sfTSLP expression in CEC.
Figure 3. Activation of peroxisome proliferator activated receptor-gamma (PPARγ) in IEC cell lines induced the expression of the short isoform of TSLP (sfTSLP). (A) Schematic representation of the structural organization of the TSLP gene with its two isoforms. Variant 1 represents the long form TSLP (lfTSLP) and variant 2 represents the short isoform (sfTSLP). The rectangles represent the exons, the gray parts corresponding to the untranslated regions and the black parts corresponding to the translated regions. The oligonucleotides used to amplify the TSLP gene are depicted. Oligonucleotides TSLP Fwd/TSLP Rev do not discriminate between both isoforms. Oligonucleotides TSLP1 Fwd/TSLP1 Rev specifically amplify lfTSLP and oligonucleotides TSLP2 Fwd/TSLP2 Rev specifically amplify sfTSLP. (B) qPCR analysis of sfTSLP gene expression in stimulated Caco-2 cells. Cells were stimulated for 24 h with each agonist. Results represent mean ± SEM (2 independent experiments in triplicate or sextuplicate, 9 < n < 12) of the fold change of TSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. (C) qPCR analysis of sfTSLP gene expression in stimulated T84 cells. Cells were stimulated for 24 h with each agonist. Results represent mean ± SEM (2 independent experiments in triplicate or sextuplicate, 6 < n < 12) of the fold change of sfTSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. (D) qPCR analysis of sfTSLP gene expression in Caco-2 ShPPARγ cells compared to Caco-2 ShLuc cells stimulated by GED and 5-ASA. Results represent mean ± SEM (two independent experiments in triplicate, n = 6) of the fold change of sfTSLP gene expression normalized to GAPDH level. The expression level measured in control cells (unstimulated ShLuc cells) was used as reference and defined as 1. Caco-2 cells were stimulated for 24 h with GW9662. Results represent mean ± SEM (two independent experiments in triplicate or sextuplicate, n = 9) of the fold change of sfTSLP gene expression normalized to GAPDH level. The expression level measured in control cells was used as reference and defined as 1. (E) sfTSLP protein expression in Caco-2 stimulated with GED and in Caco-2 ShLuc/ShPPARγ. Protein extracts were first subjected to an immunoprecipitation step with an antibody directed against TSLP (IP TSLP) or without any antibody (IP beads). sfTSLP protein was detected by western-blot in the immunoprecipitated materials. The detection of β-actin protein in the input (1% input) before immunoprecipitation was used as loading control. **P < 0.01; ***P < 0.001.
PPARγ Functionally Binds to the Promoter of sfTSLP Gene
To further confirm the regulation of sfTSLP expression by PPARγ in CECs, we next investigated the presence of PPAR response element (PPRE) sequences in the sfTSLP gene promoter. In silico analysis of the 1,000 base pairs (bp) upstream from the transcription start site of the human sfTSLP gene revealed the presence of several potential PPRE (DR1, DR2, and DR3) by which PPARγ may regulate sfTSLP gene expression (Figure 4A; Figure S2 in Supplementary Material). Chromatin immunoprecipitation analysis of these putative PPRE revealed notably that a DR3 located between −785 (bp) and −770 bp upstream of the transcription start site was bound by PPARγ within the sfTSLP gene promoter in Caco-2 cells (both in control and stimulated cells) (Figure 4B). In order to test whether this binding was functional, we constructed two reporter plasmids: in the first one, the genomic fragment corresponding to the 1,000 bp upstream from the transcription start site of the human sfTSLP gene was cloned upstream to the luciferase reporter gene into a pGL4 vector (promTSLP2-Luc construct; Figure 4C). In the second one, the genomic region containing the putative PPRE DR3 bound by PPARγ was deleted, giving "promTSLP2-Luc Δ1" construct (Figure 4C). Then, both plasmids were tested in transient reporter gene assays in Caco-2 cells (Figures 4D–F). First, in unstimulated conditions, the transfection of promTSLP2-Luc plasmids led to a significant five fold increase of luciferase activity compared to the transfection of empty pGL4-Luc vector, indicating that the portion of promoter present in the promTSLP2-Luc construct is active in Caco-2 cells (Figure 4D, compare white bar graphs). Stimulation of "promTSLP2-Luc"-transfected cells with GED or 5-ASA induced a significant additional increase of the reporter gene activity compared to unstimulated transfected cells, suggesting that putative functional PPARγ-responsive sequences are present within the genomic fragment cloned in promTSLP2-Luc construct (Figure 4D, compare white, black, and gray bar graphs in promTSLP2-Luc transfected cells). In order to test whether the DR3 identified by the ChIP experiments could be this functional element, we tested the "promTSLP2-Luc Δ1" reporter construct in transient transfection (Figure 4E). As expected, transfection of Caco-2 cells with "promTSLP2-Luc" contruct gave the same luciferase induction as previously observed and, while in unstimulated conditions, the construction "promTSLP2-Luc Δ1" retained some transcriptional activity (Figure 4E, compare white bar graphs), the inducing effect of the GED was totally lost (Figure 4E, compare white and black bar graphs in promTSLP2-Luc Δ1 transfected cells). This result strongly suggests that the DR3 found to be bound by PPARγ in ChIP experiment is functional in the sfTSLP gene promoter. To irrevocably establish the involvement of PPARγ in the regulation of the activity of the sfTSLP promoter, we transfected PPARγ knock-down Caco-2 cells with our two reporter plasmids (Figure 4F). In control cells (Caco-2 pRS cells, corresponding to Caco-2 cells having stably integrated the empty pRS vector used to express shRNA), the transfection of "promTSLP2-Luc" plasmid led to a significant increase of luciferase activity compared to cells transfected with the empty pGL4-Luc vector. The transfection of "promTSLP2-Luc Δ1" provoked a dramatic decrease of luciferase activity compared to cells transfected with the "promTSLP2-Luc" plasmid, confirming our last result and the importance of the genomic region encompassing the DR3 element in the transcriptional activity of the sfTSLP gene promoter. The knock-down of PPARγ expression in Caco-2 shPPARγ cells significantly decreased the luciferase activity of the "promTSLP2-Luc" construction (Figure 4F, compare black bar graphs), while it had no effect on the remaining transcriptional activity of the "promTSLP2-Luc Δ1" construction (Figure 4F, compare gray bar graphs). These results clearly confirmed that PPARγ is involved in the control of the activity of the sfTSLP promoter. Taking together, our results demonstrate that PPARγ binds functionally to the promoter of sfTSLP and show that PPARγ is a transcriptional regulator of sfTSLP gene.
Figure 4. Peroxisome proliferator activated receptor-gamma (PPARγ) binds functionally to the promoter of sfTSLP gene. (A) Schematic representation of the promoter of the sfTSLP gene (1,000 base pairs upstream of the transcription start site) showing the potential presence of PPAR response element predicted by in silico. (B) Picture showing PCR amplification of the 3a–4b fragment in ChIP assay from Caco-2 cells. "Control PCR" corresponds to the amplification of a genomic region unrelated to sfTSLP promoter and serves as a control of specificity for the ChIP analysis. (C) Schematic representation of the two reporter constructions used in transient transfection and reporter gene assays. (D,E) Luciferase gene reporter assays in Caco-2 cells transfected with PromTSLP2-Luc and PromTSLP2-LucΔ1 reporter constructs. Cells transfected with empty pGL4Luc plasmid were used as control. Results represent the mean ± SEM (3 independent experiments in triplicate or sextuplicate, 9 < n < 15) of the fold change of luciferase activity normalized for protein content. The normalized Luc activity obtained in unstimulated Caco-2 cells transfected with empty pGL4Luc was used as reference and defined as 1. (F) Luciferase gene reporter assays in in PPARγ knock-down Caco-2 cells transfected with PromTSLP2-Luc and PromTSLP2-LucΔ1 reporter constructs. Cells transfected with empty pGL4Luc plasmid were used as control. Results represent the mean ± SEM of luciferase activity normalized for protein content (two independent experiments in triplicate). *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant.
Decreased sfTSLP Expression in Patients with UC Correlates with PPARγ Expression
We and others have previously demonstrated that PPARγ expression is impaired in the colonic mucosa and in the CEC of patients suffering from UC (9, 10, 28). Given our results demonstrating the relationship between PPARγ and sfTSLP, we next assessed the expression level of TSLP isoforms in the colonic mucosa and CEC of UC patients and non-IBD controls. We first confirmed the significant impairment of PPARγ mRNA expression, both in healthy and injured colonic mucosa from UC patients compared to control specimens (Figure 5A). We never obtained satisfactory lfTSLP mRNA detection in our colonic patient samples, even when trying with different combinations of newly designed and already published PCR primers (26) (see Figure S1 in Supplementary Material). Interestingly, we observed that, in UC patients, the expression of sfTSLP was significantly decreased in healthy and injured mucosa compared to controls specimens (Figure 5A), and we found a significant correlation between the expression level of PPARγ and sfTSLP in the colonic mucosa of all our patient samples (UC and controls) (Figure 5A). We finally assessed the expression levels of sfTSLP and PPARγ in CEC and found similar results: sfTSLP mRNA expression level was significantly decreased specifically in purified CEC from patients with UC and correlated with PPARγ mRNA expression level (Figure 5B). Taken together, these results therefore strengthen the relationship between PPARγ and sfTSLP and support the hypothesis that, in UC, the impaired expression of PPARγ in colonic mucosa and CEC could play a role in the loss of sfTSLP expression.
Figure 5. sfTSLP expression is decreased in ulcerative colitis (UC) patients and correlates with peroxisome proliferator activated receptor-gamma (PPARγ) expression level. (A) Colonic mucosa were obtained from control subjects (n = 22) or patients with UC (healthy mucosa, n = 9; injured mucosa, n = 21). Quantitative expression of PPARγ and sfTSLP mRNA were assessed by qPCR and normalized to GAPDH level. Transcript levels of sfTSLP in colonic mucosa from both controls and UC patients were correlated with PPARγ mRNA level. P-value was determined by the non-parametric Spearman test. (B) Colonic epithelial cells (CEC) were purified from resected colon specimens of control subjects (n = 6) or untreated patients with UC (n = 8). Quantitative expression of PPARγ and sfTSLP mRNA were assessed by qPCR and normalized to GAPDH level. Transcript levels of sfTSLP in CEC from both controls and UC patients were correlated with PPARγ mRNA level. P-value was determined by the non-parametric Spearman test. Horizontal bar indicates the mean value. **P < 0.01, ***P < 0.001.
To our knowledge, the present study is the first to address the transcriptional regulation of the sfTSLP, at least in the intestine. Our results identified the nuclear receptor PPARγ as an important transcriptional regulator of sfTSLP in CEC and strongly suggest that the lack of expression of sfTSLP that we observed in the colonic mucosa and CEC of patients with UC is related to that of PPARγ.
The distinction between the two isoforms of TSLP has only been made since very recently. It is now a fundamental aspect of the biology of this cytokine because the two isoforms possess distinct functions and expression profiles (26, 27, 29). In vitro, lfTSLP expression is regulated by inflammatory stimuli. For instance, only the expression of lfTSLP is induced in normal human bronchial epithelial cells after polyI:C exposure (30). In human keratinocytes, toll-like receptors ligands (polyI:C, FSL-1, and flagellin) as well as pro-inflammatory cytokines (IFNγ, TNF, IL-1β) are potent inducers of lfTSLP, but not of sfTSLP (25, 31). Finally, exposure of Caco-2 cells to Salmonella typhimurium induces upregulation of lfTSLP protein expression concomitantly to a downregulation of sfTSLP expression (26). Consistent with these in vitro observations, lfTSLP was found to be upregulated in vivo in inflammatory conditions such as IBD, asthma or atopic dermatitis and NF-κB was identified as a critical factor for inflammation-induced expression of lfTSLP (32, 33). In terms of function, although most of the work done so far has very rarely distinguished the two isoforms, the data suggest that lfTSLP has proinflammatory properties (27, 29). Conversely, anti-inflammatory properties have been suggested, both in vitro and in vivo, for sfTSLP which is the predominant form of TSLP, constitutively expressed at steady state (26, 29). More interestingly, recent work has demonstrated that synthetic sfTSLP displays antimicrobial activity, suggesting that this isoform may act as an antimicrobial peptide (25, 27). In this context, our results appear to be highly relevant. Indeed, although the exact role of PPARγ in the intestinal tract still remains to be characterized, it has been suggested that this factor plays a key role in gut homeostasis. Depletion of PPARγ in mouse CEC increases susceptibility to experimental colitis, while activation of this receptor reduces intestinal inflammation and disease severity both in experimental models of colitis and in UC patients. One explanation of this positive role on gut homeostasis is the potential PPARγ-dependent antimicrobial barrier function. Indeed, it has been suggested that PPARγ mediates antimicrobial immunity in the colon, notably trough the control of antimicrobial β-defensin-1 and mannose-binding lectin gene expression (34, 35). Therefore, the identification of the antimicrobial peptide sfTSLP as new PPARγ-target gene in CEC broadens the role of this nuclear receptor both as an important antibacterial factor at the gut mucosal surfaces as well as a key actor during intestinal homeostasis.
To date, only one study has investigated the differential expression of the TSLP isoforms in the intestine under normal conditions and in patients suffering from IBD (26). One of the main finding of this work was that the sfTSLP/lfTSLP ratio was altered (decreased) in patients with UC due to an upregulation of lfTSLP expression in colonic mucosa from UC patients compared to control subjects, whereas sfTSLP levels were unchanged. This perturbation could reflect the loss of intestinal homeostasis and could lead (or participate) to an uncontrolled inflammatory response. However, contrary to the study of Fornasa et al., we did not detect lfTSLP mRNA, either in Caco-2 or T84 cells nor in our human colonic samples (both from control and UC patients). We used different primer pairs (our own primers and already published primers) and, although they all allowed amplifying the long form from H292 bronchial epithelial cells, no primer pair efficiently amplified lfTSLP from CEC or colonic mucosa. Despite this, we do believe that our results obtained on patient samples are not necessarily in conflict with those of Fornasa et al. (26), but could be rather in the same line. The decrease in expression of sfTSLP that we observed, in association with an apparent unmodified level of lfTSLP, results in a decrease in the sfTSLP/lfTSLP ratio as described in the work of Fornasa et al. On the other hand, the impaired expression of sfTSLP in the colonic mucosa of our patients with UC is consistent with the suggested immunoregulatory/antimicrobial role of this isoform. This decreased pattern of expression of sfTSLP in UC patients in our samples was confirmed by using the primer pair used to amplify sfTSLP by Fornasa et al. (Figure S3 in Supplementary Material). In vitro, it has been suggested that the expression of the short form is inhibited by proinflammatory stimuli (26). Because we also observed lowered sfTSLP expression in healthy mucosa from UC patients, it seems unlikely that the perturbed levels of sfTSLP are related to the inflammatory process in our samples. In addition, we did not observe any correlation between the expression levels of sfTSLP and IL-8 (Figure S4 in Supplementary Material). The significant correlation obtained between the expression levels of PPARγ and sfTSLP rather suggests that the defect of sfTSLP is related to the loss of expression of PPARγ typically observed in the CEC of UC patients. This correlation strengthens the functional link between these two factors. Moreover, these defects observed in inflamed and healthy colons of patients with UC could suggest a primary role of colonic PPARγ and sfTSLP impairment in the pathophysiology of UC. The discrepancy between the results published by Fornasa et al. and those of our study could be due to the nature of the colonic samples used. In the Fornasa study, it seems that most of the samples of UC patients came from the sigmoid colon, whereas in our work, very few samples are derived from sigmoidectomy but are rather more proximal colonic samples coming from partial or total colectomies (Table S2 in Supplementary Material). The expression profile of TSLP isoforms along the gut (proximal colon versus distal colon for example) is unknown, but it may exist some differences that could explain these divergent results. Thus, it would be important to precisely determine the expression profile of TSLP isoforms along the normal human gastrointestinal tract in order to better understand the biology of this cytokine.
It is important to note that the sfTSLP does not exist in mouse and has been isolated only in humans. Consequently, the relevance of using mice models to study the sfTSLP functions is limited. It has been suggested that intraperitoneal injection of sfTSLP slightly improves DSS-induced colitis, but the underlying mechanism was not investigated and thus remains unknown (26). Given the unique presence of sfTSLP in humans, it would be more relevant to test the antimicrobial activity of sfTSLP on commensal and pathological bacteria associated with human gut. The recent development of colonic organoids of human origin (36–38) should also make it possible to better understand the role of sfTSLP during intestinal homeostasis.
In conclusion, the present study has identified a new PPARγ target gene in CEC, confirming the key role of this nuclear receptor in antimicrobial immunity and during intestinal homeostasis. In addition, it suggests a new molecular mechanism involved in the loss of intestinal tolerance observed during UC.
Ethics Statement
A local ethics committee (Comité de Protection des Personnes Nord Ouest IV, CHRU Lille, France) approved the study and all subjects gave informed consent (No. DC-2008-642). Surgical colonic samples were obtained from patients with an established diagnosis of UC according to international criteria and from control patients (patients underwent surgery for colorectal cancer and patients for diverticulitis of the sigmoid). The detailed characteristics of patient cohort are given in Table S2 in Supplementary Material.
Author Contributions
AMM, PD, LD, and BB designed the study. AMM, AL, SS, and BB performed experiments and analysis of the data. LS collected human colonic samples and managed clinical data. AMM, LD, and BB wrote the paper and participated to the critical reading of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We acknowledge the support of the DigestScience Foundation. We deeply acknowledge Lennart Mars for the critical reading of the manuscript.
Supplementary Material
The Supplementary Material for this article can be found online at https://www.frontiersin.org/article/10.3389/fimmu.2017.01052/full#supplementary-material.
1. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol (2004) 4(12):953–64. doi:10.1038/nri1499
2. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol (2014) 14(3):141–53. doi:10.1038/nri3608
3. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol (2005) 6(5):507–14. doi:10.1038/ni1192
4. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol (2009) 2(4):340–50. doi:10.1038/mi.2009.13
5. Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 58(11):1481–9. doi:10.1136/gut.2008.175166
6. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 43(3):246–52. doi:10.1038/ng.764
7. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med (2011) 365(18):1713–25. doi:10.1056/NEJMra1102942
8. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med (2009) 361(21):2066–78. doi:10.1056/NEJMra0804647
9. Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 124(5):1265–76. doi:10.1016/S0016-5085(03)00271-3
10. Bouguen G, Langlois A, Djouina M, Branche J, Koriche D, Dewaeles E, et al. Intestinal steroidogenesis controls PPARgamma expression in the colon and is impaired during ulcerative colitis. Gut (2015) 64(6):901–10. doi:10.1136/gutjnl-2014-307618
11. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem (2008) 77:289–312. doi:10.1146/annurev.biochem.77.061307.091829
12. Bertin B, Dubuquoy L, Colombel JF, Desreumaux P. PPAR-gamma in ulcerative colitis: a novel target for intervention. Curr Drug Targets (2013) 14(12):1501–7. doi:10.2174/13894501113149990162
13. Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, et al. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut (2006) 55(8):1104–13. doi:10.1136/gut.2005.081745
14. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest (1999) 104(4):383–9. doi:10.1172/JCI7145
15. Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med (2001) 193(7):827–38. doi:10.1084/jem.193.7.827
16. Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology (2008) 134(3):688–95. doi:10.1053/j.gastro.2007.12.012
17. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem (1997) 272(30):18779–89. doi:10.1074/jbc.272.30.18779
18. Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 33:747–85. doi:10.1146/annurev-immunol-032414-112123
19. Lindemans CA, Calafiore M, Mertelsmann AM, O'Connor MH, Dudakov JA, Jenq RR, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature (2015) 528(7583):560–4. doi:10.1038/nature16460
20. Podvinec M, Kaufmann MR, Handschin C, Meyer UA. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol (2002) 16(6):1269–79. doi:10.1210/mend.16.6.0851
21. Venkatachalam G, Kumar AP, Yue LS, Pervaiz S, Clement MV, Sakharkar MK. Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human. BMC Genomics (2009) 10(Suppl 3):S5. doi:10.1186/1471-2164-10-S3-S5
22. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem (1995) 270(22):12953–6. doi:10.1074/jbc.270.22.12953
23. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med (2005) 201(8):1205–15. doi:10.1084/jem.20041948
24. Mastrofrancesco A, Kovacs D, Sarra M, Bastonini E, Cardinali G, Aspite N, et al. Preclinical studies of a specific PPARgamma modulator in the control of skin inflammation. J Invest Dermatol (2014) 134(4):1001–11. doi:10.1038/jid.2013.448
25. Bjerkan L, Schreurs O, Engen SA, Jahnsen FL, Baekkevold ES, Blix IJ, et al. The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide. Mucosal Immunol (2015) 8(1):49–56. doi:10.1038/mi.2014.41
26. Fornasa G, Tsilingiri K, Caprioli F, Botti F, Mapelli M, Meller S, et al. Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin. J Allergy Clin Immunol (2015) 136(2):413–22. doi:10.1016/j.jaci.2015.04.011
27. Bjerkan L, Sonesson A, Schenck K. Multiple functions of the new cytokine-based antimicrobial peptide thymic stromal lymphopoietin (TSLP). Pharmaceuticals (Basel) (2016) 9(3):41. doi:10.3390/ph9030041
28. Pedersen G, Brynskov J. Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity. Am J Gastroenterol (2010) 105(7):1595–603. doi:10.1038/ajg.2009.749
29. Dong H, Hu Y, Liu L, Zou M, Huang C, Luo L, et al. Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption. Sci Rep (2016) 6:39559. doi:10.1038/srep39559
30. Harada M, Hirota T, Jodo AI, Doi S, Kameda M, Fujita K, et al. Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol (2009) 40(3):368–74. doi:10.1165/rcmb.2008-0041OC
31. Xie Y, Takai T, Chen X, Okumura K, Ogawa H. Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes. J Dermatol Sci (2012) 66(3):233–7. doi:10.1016/j.jdermsci.2012.03.007
32. Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci U S A (2007) 104(3):914–9. doi:10.1073/pnas.0607305104
33. Cultrone A, de Wouters T, Lakhdari O, Kelly D, Mulder I, Logan E, et al. The NF-kappaB binding site located in the proximal region of the TSLP promoter is critical for TSLP modulation in human intestinal epithelial cells. Eur J Immunol (2013) 43(4):1053–62. doi:10.1002/eji.201142340
34. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 107(19):8772–7. doi:10.1073/pnas.0905745107
35. Choteau L, Parny M, Francois N, Bertin B, Fumery M, Dubuquoy L, et al. Role of mannose-binding lectin in intestinal homeostasis and fungal elimination. Mucosal Immunol (2016) 9(3):767–76. doi:10.1038/mi.2015.100
36. Miyoshi H, Stappenbeck TS. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat Protoc (2013) 8(12):2471–82. doi:10.1038/nprot.2013.153
37. VanDussen KL, Marinshaw JM, Shaikh N, Miyoshi H, Moon C, Tarr PI, et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut (2014) 64(6):911–20. doi:10.1136/gutjnl-2013-306651
38. Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol (2016) 18(3):246–54. doi:10.1038/ncb3312
Keywords: PPARgamma, thymic stromal lymphopoietin, intestinal epithelial cells, ulcerative colitis, colon
Citation: Martin Mena A, Langlois A, Speca S, Schneider L, Desreumaux P, Dubuquoy L and Bertin B (2017) The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis. Front. Immunol. 8:1052. doi: 10.3389/fimmu.2017.01052
Received: 08 June 2017; Accepted: 14 August 2017;
Published: 04 September 2017
Edited by:Eric Cox, Ghent University, Belgium
Reviewed by:Luca Pastorelli, Università degli Studi di Milano, Italy
Bruce Vallance, University of British Columbia, Canada
Copyright: © 2017 Martin Mena, Langlois, Speca, Schneider, Desreumaux, Dubuquoy and Bertin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Benjamin Bertin, email@example.com


text:
E1 42: One View Open Sales Inquiry (P42270) Unable to Run Advanced Query with a Form Using a Required Field
Last updated on MARCH 14, 2016
Applies to:JD Edwards EnterpriseOne One View Sales Order Management - Version 9.1 to 9.1 [Release 9.1]
Information in this document applies to any platform.
When user chooses an advanced query name for which the field has already been defined, the system does not run the advanced query and throws an error message "Required filter criteria not entered"
Sign In with your My Oracle Support account
Don't have a My Oracle Support account? Click to get started
My Oracle Support provides customers with access to over a
Million Knowledge Articles and hundreds of Community platforms


text:
Science shows that the ketogenic diet is an effective way to lower blood sugar in diabetes, control insulin resistance, and optimize cholesterol. One of the most.
Weight loss. By rebalancing your body's chemistry, weight loss and/or improved weight management becomes nearly effortless. Studies have shown a ketogenic diet can.
Learn the benefits of the ketogenic diet for weight loss, energy, and better health.
Benefits of the Keto Diet for diabetics. If you are a diabetic considering the ketogenic diet, here is a list of what you should consider.
Fibre is the only way to get butyrate. Even though it seems likely that a fibre-free ketogenic diet is not only sufficient for colon health, but better for treating.
How The Body Adapts To The Ketogenic Diet — The Main Reason for Many of the Benefits. From The Cell's Point of View. Carbohydrates are the body's preferred fuel.
6 Things That Happen to Your Body When You Go On a Ketogenic Diet Keto is incredibly trendy – but the side effects can be a bit gnarly By Isadora Baum September 25.
Keto Crepes And Pancakes South Asia's own version of pancakes., Malpura is made on celebratory occasions. It's a breakfast item, which is served with milk or tea, early morning before Eid or before an early walk during December. The Malpura is a regional favourite. You've heard it before – breakfast is the most important meal of the day! Why
Power Yoga Flow Asanas Power yoga describes a vigorous, fitness-based approach to vinyasa-style yoga. See what to expect at a class of this style and how it was developed. Power Vinyasa Flow Yoga is a powerful, energetic form of yoga where students fluidly move from one pose to the next while connecting their breathing to their movements. No Carbs
Are you ready for the cold dark days that come with Daylight Saving Time? Prepare for winter skin before turning your.
Ketosis is a metabolic state in which some of the body's energy supply comes from ketone bodies in the blood, in contrast to a state of glycolysis in which blood.
First, though, there is an important reason why the argument doesn't make sense. We already know that a ketogenic diet effectively treats metabolic syndrome.
Catalyst online reporter Roslyn Lawrence takes on the challenge of a ketogenic diet for six weeks
Source: Christian B. Allan, PhD and Wolfgang Lutz, MD, Life Without Bread. There are several very complicated steps in making ATP within mitochondria, but a look at 5.
High Blood Sugar In Ketogenic Dieters! Plus A Special Surprise (Hint: Genotypes And Metabolism)! Posted on Monday, February 18th, 2013 at 7:07 am.
Ketogenic.com is the authoritative resource for Education, Recipes, Articles, FAQs and more! Take an evidence based approach to a Ketogenic lifestyle!
Read more about a ketogenic diet & the paleo diet. Browse The Paleo Diet™ blog to learn more about paleo foods, diet plans, paleo recipes & more today!
Are you ready for the cold dark days that come with Daylight Saving Time? Prepare for winter skin before turning your.
Swerve Studio Yoga Booty Ballet has classes in everything from high-intensity interval training to yoga for $35 each. The enterprise promotes rising fitness stars, encouraging them to create passion projects and work with other trainers to form unique mash-ups like a dance. But after seeing Janelle Monae's booty-popping new video for "Yoga," I think I might be doing it wrong.
The Ketogenic Diet Vs The Atkins Diet: Do you know which is better? Let's put the methodologies back-to-back and see which low carb diets will reign.


text:
The annual Audi Club RMC Mystery Rally is back! Where are we going? Who knows!?
Date: October 7, 2017
Time: 8:00 a.m.
Meet at: Audi Flatirons, 13321 West Midway Boulevard, Broomfield, CO 80020
Register here: …
Added by Jeannine Horan on September 22, 2017 at 1:45pm — No Comments
Ladies! Join us for our next fun-run of 2017! Squaw Pass is one of the Top 9 locations in Colorado for foliage!
Meet at the T-Rex Hogback Park-n-Ride: Located off I-70 at exit 259 to Morrison, US 40
Date: Wednesday, September 20, 2017
Time: 6:00 p.m.…Continue
Added by Jeannine Horan on September 15, 2017 at 10:28am — No Comments
Bring your fun car and let's go to the track! Come get an instructional ride in a 2011 GT3 Cup Car as well for a donation to Front Range German Shepherd Rescue …Continue
Added by Dale Hartzell on August 17, 2017 at 9:28am — No Comments
And all of that is within the span of…Continue
Added by Jeannine Horan on August 8, 2017 at 12:22pm — 1 Comment
Come join us for the 31 Annual Wheels for Meals Car Show
(New Name, New Format, Same Great Time!)
2017 marks the 31st anniversary of Ed Carroll's Car Show benefitting Meals on Wheels Fort Collins, who provides a nutritious hot meal,…Continue
Added by Jeannine Horan on July 27, 2017 at 11:32am — No Comments
Added by Chris Sarian on July 25, 2017 at 11:47am — No Comments
Ladies! Join us for our fun-run through Golden Gate Canyon! (Here's hoping for good weather!)
Meet at Home Depot in Golden on Wednesday, July 19, 2017 at 6:00 p.m.
Come join us for a fun, stunning drive through Golden Gate Canyon! It's a fun…Continue
Added by Jeannine Horan on July 11, 2017 at 6:36pm — No Comments
Added by Chris Sarian on May 18, 2017 at 11:56am — No Comments
Be sure to join us! Register and have fun...Looking forward to seeing you there!…
Added by Jeannine Horan on May 15, 2017 at 11:55am — No Comments
3 Zero 3 Motorsports ~ Evening Get Together ~ Thurs, May 11th
from 6-8 PM
Join us for an evening get together at…Continue
Added by Jeannine Horan on May 9, 2017 at 12:19pm — No Comments
Regrettably, the ice on Georgetown Lake has melted. There is even open water showing. Unfortunately, we have had to cancel this weekend's ice driving events. If you registered for an event, you will receive a refund. We are working on new ideas for next year's ice driving events, so please keep in touch!
Added by Jeannine Horan on February 15, 2017 at 12:46pm — No Comments
Quattrokana ™ - The ACNA / RMC First Gear and Advanced adult/teen winter ice driving schools are held on the frozen surface of Georgetown Lake. Participants will start their day at the Georgetown Community Center to review a short presentation covering safety, winter driving techniques and schedule. After the presentation, participants will put their cars through exercises on varied snow and ice conditions. These winter driving schools fill up quickly, so register…Continue
Added by Connie Johnson on December 9, 2016 at 4:03pm — No Comments
ACNA/RMC Club Members and guests - Please join us for a special evening at the Denver Athletic Club ("DAC") in downtown Denver, CO for our 2016 Annual Board of Directors Meeting and Dinner/Social.
We will be meeting in the historic DAC Tavern/Founders Room with cash bar at 6:00 for networking and…Continue
Added by Jeannine Horan on November 23, 2016 at 1:19pm — No Comments
The LAST Porsche Club Track Event of 2016 is only 28 days away on Oct 8-9 so REGISTER TODAY!
The OktoberFAST DE at High Plains Raceway is the last DE this year. What is a DE and why do you want to attend? A DE is High Speed Driver's Education - you own the car, why not learn from experienced PCA and BMWCCA instructors how to drive fast and safe on a race track. Your Audi was made for this and you'll be amazed at what your car can do and what you can do as a…
Added by Dale Hartzell on September 12, 2016 at 9:43am — No Comments
Added by Chris Sarian on July 5, 2016 at 2:33pm — No Comments
Added by Chris Sarian on May 25, 2016 at 12:09pm — No Comments
Added by Chris Sarian on April 14, 2016 at 11:32am — No Comments
Added by Chris Sarian on April 14, 2016 at 11:30am — No Comments
Added by Chris Sarian on April 11, 2016 at 1:49pm — No Comments
Added by Chris Sarian on April 6, 2016 at 1:23pm — No Comments